🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Multiple myeloma is a disease of B-lymphocytes producing malignant plasma c...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2000-08
Trial ID
NCT00171925
Treatments Being Tested
This research will help us to learn if the medicine called metformin reduce...
Status
Recruiting
Location
Phoenix VA Health Care System, Phoenix, AZ
Start Date
2023-04-03
Trial ID
NCT02915198
Treatments Being Tested
The aim of this study is to compare the effectiveness of standard epidural ...
Status
Completed
Location
Atatürk University
Start Date
2022-08-15
Trial ID
NCT05408052
Treatments Being Tested
The purpose of this study is to assess the safety and potential efficacy of...
Status
Completed
Location
NewportNativeMD
Start Date
2022-04-14
Trial ID
NCT05228899
This is an open-label, single-arm, pharmacokinetic and safety study of Likm...
Status
Not Yet Recruiting
Location
Bioresearch Partner
Start Date
2025-08
Trial ID
NCT07146217
Treatments Being Tested
Protocol Summary * Title: A Phase I study of ExoFlo, an ex vivo culture-ex...
Status
Terminated
Location
Direct Biologics Investigational Site
Start Date
2022-12-19
Trial ID
NCT05176366
Treatments Being Tested
Open-label, parallel, 2-arm, fixed-sequence study to investigate the effect...
Status
Completed
Location
QPS Missouri
Start Date
2020-10-24
Trial ID
NCT04606537
Treatments Being Tested